Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and S-1 with or without radiotherapy in locally advanced pancreatic cancer
NCT01430052Phase 2Completed
- Sponsor
- Osaka International Cancer Institute
- Start
- Apr 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, tegafur in pancreatic cancer (PC), sponsored by Osaka International Cancer Institute. Started Apr 2009; status: completed.
02
Drugs
gemcitabinetegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01430052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430052.